These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35884598)

  • 1. Urine Cellular DNA Point Mutation and Methylation for Identifying Upper Tract Urinary Carcinoma.
    Ouyang W; Luo L; Zhang J; Xu R; Lu Q; Xu Z; Liu J; Li P; Zhang Y; Zhou C; Tang W; Wang Z; Cao M; Xu G; Wang L
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Urine-Based Liquid Biopsy Method for Detection of Upper Tract Urinary Carcinoma.
    Xu Y; Ma X; Ai X; Gao J; Liang Y; Zhang Q; Ma T; Mao K; Zheng Q; Wang S; Jiao Y; Zhang X; Li H
    Front Oncol; 2020; 10():597486. PubMed ID: 33634022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy.
    van Kessel KE; Beukers W; Lurkin I; Ziel-van der Made A; van der Keur KA; Boormans JL; Dyrskjøt L; Márquez M; Ørntoft TF; Real FX; Segersten U; Malats N; Malmström PU; Van Criekinge W; Zwarthoff EC
    J Urol; 2017 Mar; 197(3 Pt 1):590-595. PubMed ID: 27746284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma.
    Hayashi Y; Fujita K; Matsuzaki K; Matsushita M; Kawamura N; Koh Y; Nakano K; Wang C; Ishizuya Y; Yamamoto Y; Jingushi K; Kato T; Kawashima A; Ujike T; Nagahara A; Uemura M; Imamura R; Takao T; Takada S; Netto GJ; Nonomura N
    Cancer Sci; 2019 May; 110(5):1771-1779. PubMed ID: 30887605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Methylation Marker NRN1 plus TERT and FGFR3 Mutation Using Urine Sediment Enables the Detection of Urothelial Bladder Carcinoma.
    Zhang J; Xu R; Lu Q; Xu Z; Liu J; Li P; Zhang Y; Zhou C; Luo L; Tang W; Wang Z; Cao M; Cao J; Xu G; Wang L
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale Prospective Validation Study of a Multiplex RNA Urine Test for Noninvasive Detection of Upper Tract Urothelial Carcinoma.
    Zhang H; Xu Y; Wang K; Zheng C; Li Y; Gong H; Liu C; Sheng M; Xu Q; Sun Y; Chen J; Zhang X; Zhang C; Zhang H; Wang W
    Eur Urol Oncol; 2024 Mar; ():. PubMed ID: 38523018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of diagnostic criteria for upper urinary tract urothelial carcinoma based on genome-wide DNA methylation analysis.
    Fujimoto M; Arai E; Tsumura K; Yotani T; Yamada Y; Takahashi Y; Maeshima AM; Fujimoto H; Yoshida T; Kanai Y
    Epigenetics; 2020 Dec; 15(12):1289-1301. PubMed ID: 32498593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples.
    Pierconti F; Martini M; Fiorentino V; Cenci T; Racioppi M; Foschi N; Di Gianfrancesco L; Sacco E; Rossi E; Larocca LM; Bassi PF
    Hum Pathol; 2021 Dec; 118():42-48. PubMed ID: 34582934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer.
    Roperch JP; Grandchamp B; Desgrandchamps F; Mongiat-Artus P; Ravery V; Ouzaid I; Roupret M; Phe V; Ciofu C; Tubach F; Cussenot O; Incitti R
    BMC Cancer; 2016 Sep; 16(1):704. PubMed ID: 27586786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation.
    Monteiro-Reis S; Leça L; Almeida M; Antunes L; Monteiro P; Dias PC; Morais A; Oliveira J; Henrique R; Jerónimo C
    Eur J Cancer; 2014 Jan; 50(1):226-33. PubMed ID: 24100025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study.
    Guo RQ; Xiong GY; Yang KW; Zhang L; He SM; Gong YQ; He Q; Li XY; Wang ZC; Bao ZQ; Li XS; Zhang K; Zhou LQ
    Urol Oncol; 2018 Jul; 36(7):342.e15-342.e23. PubMed ID: 29706459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence in situ hybridization in 1 mL of selective urine for the detection of upper tract urothelial carcinoma: a feasibility study.
    Freund JE; Liem EIML; Savci-Heijink CD; de Reijke TM
    Med Oncol; 2018 Nov; 36(1):10. PubMed ID: 30499061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria.
    van Kessel KE; Van Neste L; Lurkin I; Zwarthoff EC; Van Criekinge W
    J Urol; 2016 Mar; 195(3):601-7. PubMed ID: 26327355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
    Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ
    Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Characterization of Upper Tract Urothelial Carcinoma.
    Sfakianos JP; Cha EK; Iyer G; Scott SN; Zabor EC; Shah RH; Ren Q; Bagrodia A; Kim PH; Hakimi AA; Ostrovnaya I; Ramirez R; Hanrahan AJ; Desai NB; Sun A; Pinciroli P; Rosenberg JE; Dalbagni G; Schultz N; Bajorin DF; Reuter VE; Berger MF; Bochner BH; Al-Ahmadie HA; Solit DB; Coleman JA
    Eur Urol; 2015 Dec; 68(6):970-7. PubMed ID: 26278805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methylation status of RASSF1A gene promoter in upper tract urothelial carcinoma and its clinical significance].
    Liu J; Xiong GY; Tang Q; Fang D; Li XS; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):571-578. PubMed ID: 29263491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma.
    Favaretto RL; Shariat SF; Savage C; Godoy G; Chade DC; Kaag M; Bochner BH; Coleman J; Dalbagni G
    BJU Int; 2012 Jan; 109(1):77-82. PubMed ID: 21631698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical, ureteroscopic and photodynamic diagnosis of urothelial carcinomas of the upper tract: state-of-the art review for the yearly scientific report of the French National Association of Urology].
    Nison L; Bozzini G; Rouprêt M; Traxer O; Colin P
    Prog Urol; 2014 Nov; 24(15):977-86. PubMed ID: 25199724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria.
    Wu Y; Jiang G; Zhang N; Liu S; Lin X; Perschon C; Zheng SL; Ding Q; Wang X; Na R; Sun J; Xu J
    Eur Urol Focus; 2020 Mar; 6(2):284-291. PubMed ID: 30309818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Ureteroscopy for Cases Clinically Suspected of Carcinoma in Situ of the Upper Urinary Tract.
    Sasaki K; Wada K; Araki M; Kobayashi Y; Sugimoto M; Ebara S; Watanabe T; Nasu Y
    Acta Med Okayama; 2017 Jun; 71(3):227-232. PubMed ID: 28655942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.